New dye test could spot Flesh-Eating bacteria in minutes
NCT ID NCT06877793
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a safe, FDA-approved dye called indocyanine green (ICG) can help doctors quickly tell the difference between a life-threatening flesh-eating infection (necrotizing fasciitis) and a less dangerous skin infection. About 420 adults with suspected infections will receive the dye and have special camera images taken. The goal is to see if the dye's movement through tissue reveals blocked blood vessels, a hallmark of necrotizing infections, enabling faster and more accurate diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
indocyanine green (ICG) dye
What this could lead to
If successful, this could give doctors a fast, accurate way to diagnose necrotizing fasciitis in the emergency room, reducing delays and improving survival.
What could go wrong
This is an early-stage study testing a new use for an existing dye. It may not prove accurate enough across different hospitals or bacteria types, and false results could still occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NECROTIZING FASCITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dartmouth-Hitchcock Medical Center
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
-
Emory University/Grady Memorial Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Stanford University
RECRUITINGStanford, California, 94305, United States
Contact
Contact Email: •••••@•••••
Contact
-
University of California, Los Angeles
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48104, United States
Contact Email: •••••@•••••
Contact
Contact
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact Email: •••••@•••••
Contact
Contact
-
University of Pittsburgh Medical Center
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Vanderbilt University
RECRUITINGNashville, Tennessee, 37235, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact